THERAPY FOOTPRINT

Novartis turning to technology to manage business: Bertrand Bodson, Chief Digital Officer

Swiss drugmaker Novartis is turning to tech to deal with the pharma business in times of pandemic, as companies go virtual. Bertrand Bodson, chief digital officer, Novartis, in an interview shares how the company is innovating its business in the time of pandemic.

Biocon to expand generic drugs business with DKSH

As a part of the pact, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon’s brand in these key Asian markets.

Value Pick: Anand Rathi has buy on Cipla, target price Rs 738

The brokerage believes that with healthy earnings growth and core ROCE expansion over FY20-22e, Cipla’s valuations are likely to witness re-rating.

ET Q&A: Need Government investments to develop cure for epidemics like Covid-19

In the absence of sustained investments by government, the cure for epidemics such as Covid-19 becomes a challenge, Novartis global CEO Vasant (Vas) Narasimhan tells ET.

Zero-footprint, green cruises, virtual reality spas: Welcome to travel in 2020

If travel became a competitive sport in the last 10 years, it’s starting to loosen up.

misters.in raises about $1 million in seed funding led by Sauce.vc, Rainforest Ventures & angel investors

The company’s mission is not only to put together and offer the very best products that science has to offer, through its AI-driven platform but also to get the country to talk about sex.

When NY fashion comes calling: Kenneth Cole debuts in India; Mumbai store promises a powerful dose of retail therapy

The global fashion brand has opened its first flagship store in India at Infiniti Mall, Malad.

Femina FLAUNT enters beauty business

The new venture has logged sales in excess of Rs 200 million since its launch.

Another 700 jobs would be meanwhile be cut over the same period due to a shift in business functions from Switzerland to other Novartis sites around the world, according to the company, which currently employs some 12,800 people in Switzerland.

GST: Positive for bigger companies in pharma & chemical sector, while unorganised sector has struggled

Manshukh Mandaviya, the Minister of State for Chemicals & Fertilizers, has informed that there will be almost no impact on the prices of non-scheduled formulations which account for nearly 80% of the pharmaceuticals sector.

Dr Reddy’s agrees to buy UCB business in India for Rs 800 crore

The deal will help Dr Reddy's strengthen its presence in dermatology, pediatrics and respiratory products, the company said in a statement to the Bombay Stock Exchange.

The transaction will provide a number of long-term growth opportunities for Baxter around the world.